CD16 (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "CD16" in Czech language version.

refsWebsite
Global rank Czech rank
4th place
8th place
5th place
3rd place
2nd place
4th place
4,380th place
low place
6th place
10th place
234th place
72nd place
low place
5,054th place
2,912th place
482nd place
low place
low place
274th place
174th place

archive.org

doi.org

dx.doi.org

  • GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429 PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN 1097-4172. DOI 10.1016/j.cell.2021.12.040. PMID 35032429. 
  • MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937 PMCID: PMC21913. Dostupné online [cit. 2022-06-21]. ISSN 0027-8424. DOI 10.1073/pnas.96.10.5640. PMID 10318937. 
  • TAKAI, Toshiyuki. Roles of Fc receptors in autoimmunity. Nature Reviews Immunology. 2002-08, roč. 2, čís. 8, s. 580–592. Dostupné online [cit. 2022-06-21]. ISSN 1474-1741. DOI 10.1038/nri856. (anglicky) 
  • Zhang Y, Boesen CC, Radaev S, Brooks AG, Fridman WH, Sautes-Fridman C, Sun PD. Crystal structure of the extracellular domain of a human FcγRIII. Immunity. September 2000, s. 387–95. DOI 10.1016/S1074-7613(00)00038-8. PMID 11021536. 
  • ZHANG, Y.; BOESEN, C. C.; RADAEV, S. Crystal structure of the extracellular domain of a human Fc gamma RIII. Immunity. 2000-09, roč. 13, čís. 3, s. 387–395. PMID: 11021536. Dostupné online [cit. 2022-06-22]. ISSN 1074-7613. DOI 10.1016/s1074-7613(00)00038-8. PMID 11021536. 
  • MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937 PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN 0027-8424. DOI 10.1073/pnas.96.10.5640. PMID 10318937. 
  • AICHELER, Rebecca J.; WANG, Eddie C. Y.; TOMASEC, Peter. Potential for Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity for Control of Human Cytomegalovirus. Antibodies. 2013-12, roč. 2, čís. 4, s. 617–635. Dostupné online [cit. 2022-06-21]. ISSN 2073-4468. DOI 10.3390/antib2040617. (anglicky) 
  • MAROIS, Louis; PARÉ, Guillaume; VAILLANCOURT, Myriam. Fc gammaRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils. The Journal of Biological Chemistry. 2011-02-04, roč. 286, čís. 5, s. 3509–3519. PMID: 21123174 PMCID: PMC3030356. Dostupné online [cit. 2022-06-21]. ISSN 1083-351X. DOI 10.1074/jbc.M110.169516. PMID 21123174. 
  • GREEN, J. M.; SCHREIBER, A. D.; BROWN, E. J. Role for a glycan phosphoinositol anchor in Fc gamma receptor synergy. The Journal of Cell Biology. 1997-12-01, roč. 139, čís. 5, s. 1209–1217. PMID: 9382867 PMCID: PMC2140207. Dostupné online [cit. 2022-06-21]. ISSN 0021-9525. DOI 10.1083/jcb.139.5.1209. PMID 9382867. 
  • MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937 PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN 0027-8424. DOI 10.1073/pnas.96.10.5640. PMID 10318937. 
  • ANEGÓN, I.; CUTURI, M. C.; TRINCHIERI, G. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. The Journal of Experimental Medicine. 1988-02-01, roč. 167, čís. 2, s. 452–472. PMID: 2831292 PMCID: PMC2188858. Dostupné online [cit. 2022-06-21]. ISSN 0022-1007. DOI 10.1084/jem.167.2.452. PMID 2831292. 
  • ARAMBURU, J.; AZZONI, L.; RAO, A. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. The Journal of Experimental Medicine. 1995-09-01, roč. 182, čís. 3, s. 801–810. PMID: 7650486 PMCID: PMC2192167. Dostupné online [cit. 2022-06-21]. ISSN 0022-1007. DOI 10.1084/jem.182.3.801. PMID 7650486. 
  • GARMAN, S. C.; KINET, J. P.; JARDETZKY, T. S. Crystal structure of the human high-affinity IgE receptor. Cell. 1998-12-23, roč. 95, čís. 7, s. 951–961. PMID: 9875849. Dostupné online [cit. 2022-06-21]. ISSN 0092-8674. DOI 10.1016/s0092-8674(00)81719-5. PMID 9875849. 
  • KOENE, H. R.; KLEIJER, M.; SWAAK, A. J. The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis and Rheumatism. 1998-10, roč. 41, čís. 10, s. 1813–1818. PMID: 9778222. Dostupné online [cit. 2022-06-21]. ISSN 0004-3591. DOI 10.1002/1529-0131(199810)41:10<1813::AID-ART13>3.0.CO;2-6. PMID 9778222. 
  • VEDELER, C. A.; RAKNES, G.; MYHR, K. M. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology. 2000-09-12, roč. 55, čís. 5, s. 705–707. PMID: 10980740. Dostupné online [cit. 2022-06-21]. ISSN 0028-3878. DOI 10.1212/wnl.55.5.705. PMID 10980740. 
  • GOODIER, Martin R.; LUSA, Chiara; SHERRATT, Sam. Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function. Frontiers in Immunology. 2016, roč. 7, s. 384. PMID: 27725819 PMCID: PMC5035824. Dostupné online [cit. 2022-06-21]. ISSN 1664-3224. DOI 10.3389/fimmu.2016.00384. PMID 27725819. 
  • PILLAY, Janesh; TAK, Tamar; KAMP, Vera M. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cellular and molecular life sciences: CMLS. 2013-10, roč. 70, čís. 20, s. 3813–3827. PMID: 23423530 PMCID: PMC3781313. Dostupné online [cit. 2022-06-21]. ISSN 1420-9071. DOI 10.1007/s00018-013-1286-4. PMID 23423530. 
  • DUMITRU, Claudia A.; MOSES, Katrin; TRELLAKIS, Sokratis. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer immunology, immunotherapy: CII. 2012-08, roč. 61, čís. 8, s. 1155–1167. PMID: 22692756. Dostupné online [cit. 2022-06-21]. ISSN 1432-0851. DOI 10.1007/s00262-012-1294-5. PMID 22692756. 
  • ELGHETANY, M. Tarek. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells, Molecules & Diseases. 2002-03, roč. 28, čís. 2, s. 260–274. PMID: 12064921. Dostupné online [cit. 2022-06-21]. ISSN 1079-9796. DOI 10.1006/bcmd.2002.0513. PMID 12064921. 
  • BJÖRKSTRÖM, Niklas K.; GONZALEZ, Veronica D.; MALMBERG, Karl-Johan. Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection. Journal of Immunology (Baltimore, Md.: 1950). 2008-09-15, roč. 181, čís. 6, s. 4219–4228. PMID: 18768879. Dostupné online [cit. 2022-06-21]. ISSN 1550-6606. DOI 10.4049/jimmunol.181.6.4219. PMID 18768879. 
  • CLÉMENCEAU, Béatrice; VIVIEN, Régine; DEBEAUPUIS, Emilie. FcγRIIIa (CD16) induction on human T lymphocytes and CD16pos T-lymphocyte amplification. Journal of Immunotherapy (Hagerstown, Md.: 1997). 2011-09, roč. 34, čís. 7, s. 542–549. PMID: 21760529. Dostupné online [cit. 2022-06-21]. ISSN 1537-4513. DOI 10.1097/CJI.0b013e31822801d4. PMID 21760529. 
  • JACQUEMONT, Lola; TILLY, Gaëlle; YAP, Michelle. Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. Journal of the American Society of Nephrology: JASN. 2020-04, roč. 31, čís. 4, s. 876–891. PMID: 32165419 PMCID: PMC7191929. Dostupné online [cit. 2022-06-21]. ISSN 1533-3450. DOI 10.1681/ASN.2019080847. PMID 32165419. 
  • GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429 PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN 1097-4172. DOI 10.1016/j.cell.2021.12.040. PMID 35032429. 
  • LU, Yu; HUANG, Yizhou; HUANG, Lei. CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients. BMC immunology. 2020-08-08, roč. 21, čís. 1, s. 46. PMID: 32770940 PMCID: PMC7414545. Dostupné online [cit. 2022-06-22]. ISSN 1471-2172. DOI 10.1186/s12865-020-00375-8. PMID 32770940. 
  • GRIER, Jennifer T.; FORBES, Lisa R.; MONACO-SHAWVER, Linda. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. The Journal of Clinical Investigation. 2012-10, roč. 122, čís. 10, s. 3769–3780. PMID: 23006327 PMCID: PMC3461929. Dostupné online [cit. 2022-06-22]. ISSN 1558-8238. DOI 10.1172/JCI64837. PMID 23006327. 
  • SHARMA, Naveen; VACHER, Jean; ALLISON, James P. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proceedings of the National Academy of Sciences of the United States of America. 2019-05-21, roč. 116, čís. 21, s. 10453–10462. PMID: 31076558 PMCID: PMC6534983. Dostupné online [cit. 2022-06-21]. ISSN 1091-6490. DOI 10.1073/pnas.1819004116. PMID 31076558. 
  • SCHRAMA, David; REISFELD, Ralph A.; BECKER, Jürgen C. Antibody targeted drugs as cancer therapeutics. Nature Reviews. Drug Discovery. 2006-02, roč. 5, čís. 2, s. 147–159. PMID: 16424916. Dostupné online [cit. 2022-06-21]. ISSN 1474-1776. DOI 10.1038/nrd1957. PMID 16424916. 

jimmunol.org

  • GALON, J.; GAUCHAT, J. F.; MAZIÈRES, N. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors.. The Journal of Immunology. 1996-08-01, roč. 157, čís. 3, s. 1184–1192. PMID: 8757624. Dostupné online [cit. 2022-06-21]. ISSN 0022-1767. PMID 8757624. (anglicky) 

malacards.org

mdpi.com

  • AICHELER, Rebecca J.; WANG, Eddie C. Y.; TOMASEC, Peter. Potential for Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity for Control of Human Cytomegalovirus. Antibodies. 2013-12, roč. 2, čís. 4, s. 617–635. Dostupné online [cit. 2022-06-21]. ISSN 2073-4468. DOI 10.3390/antib2040617. (anglicky) 

nature.com

nih.gov

ncbi.nlm.nih.gov

  • GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429 PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN 1097-4172. DOI 10.1016/j.cell.2021.12.040. PMID 35032429. 
  • VIVIER, E.; MORIN, P.; O'BRIEN, C. Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. Journal of Immunology (Baltimore, Md.: 1950). 1991-01-01, roč. 146, čís. 1, s. 206–210. PMID: 1701792. Dostupné online [cit. 2022-06-21]. ISSN 0022-1767. PMID 1701792. 
  • MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937 PMCID: PMC21913. Dostupné online [cit. 2022-06-21]. ISSN 0027-8424. DOI 10.1073/pnas.96.10.5640. PMID 10318937. 
  • Zhang Y, Boesen CC, Radaev S, Brooks AG, Fridman WH, Sautes-Fridman C, Sun PD. Crystal structure of the extracellular domain of a human FcγRIII. Immunity. September 2000, s. 387–95. DOI 10.1016/S1074-7613(00)00038-8. PMID 11021536. 
  • ZHANG, Y.; BOESEN, C. C.; RADAEV, S. Crystal structure of the extracellular domain of a human Fc gamma RIII. Immunity. 2000-09, roč. 13, čís. 3, s. 387–395. PMID: 11021536. Dostupné online [cit. 2022-06-22]. ISSN 1074-7613. DOI 10.1016/s1074-7613(00)00038-8. PMID 11021536. 
  • GALON, J.; GAUCHAT, J. F.; MAZIÈRES, N. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors.. The Journal of Immunology. 1996-08-01, roč. 157, čís. 3, s. 1184–1192. PMID: 8757624. Dostupné online [cit. 2022-06-21]. ISSN 0022-1767. PMID 8757624. (anglicky) 
  • MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937 PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN 0027-8424. DOI 10.1073/pnas.96.10.5640. PMID 10318937. 
  • MAROIS, Louis; PARÉ, Guillaume; VAILLANCOURT, Myriam. Fc gammaRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils. The Journal of Biological Chemistry. 2011-02-04, roč. 286, čís. 5, s. 3509–3519. PMID: 21123174 PMCID: PMC3030356. Dostupné online [cit. 2022-06-21]. ISSN 1083-351X. DOI 10.1074/jbc.M110.169516. PMID 21123174. 
  • GREEN, J. M.; SCHREIBER, A. D.; BROWN, E. J. Role for a glycan phosphoinositol anchor in Fc gamma receptor synergy. The Journal of Cell Biology. 1997-12-01, roč. 139, čís. 5, s. 1209–1217. PMID: 9382867 PMCID: PMC2140207. Dostupné online [cit. 2022-06-21]. ISSN 0021-9525. DOI 10.1083/jcb.139.5.1209. PMID 9382867. 
  • MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937 PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN 0027-8424. DOI 10.1073/pnas.96.10.5640. PMID 10318937. 
  • ANEGÓN, I.; CUTURI, M. C.; TRINCHIERI, G. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. The Journal of Experimental Medicine. 1988-02-01, roč. 167, čís. 2, s. 452–472. PMID: 2831292 PMCID: PMC2188858. Dostupné online [cit. 2022-06-21]. ISSN 0022-1007. DOI 10.1084/jem.167.2.452. PMID 2831292. 
  • ARAMBURU, J.; AZZONI, L.; RAO, A. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. The Journal of Experimental Medicine. 1995-09-01, roč. 182, čís. 3, s. 801–810. PMID: 7650486 PMCID: PMC2192167. Dostupné online [cit. 2022-06-21]. ISSN 0022-1007. DOI 10.1084/jem.182.3.801. PMID 7650486. 
  • GARMAN, S. C.; KINET, J. P.; JARDETZKY, T. S. Crystal structure of the human high-affinity IgE receptor. Cell. 1998-12-23, roč. 95, čís. 7, s. 951–961. PMID: 9875849. Dostupné online [cit. 2022-06-21]. ISSN 0092-8674. DOI 10.1016/s0092-8674(00)81719-5. PMID 9875849. 
  • KOENE, H. R.; KLEIJER, M.; SWAAK, A. J. The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis and Rheumatism. 1998-10, roč. 41, čís. 10, s. 1813–1818. PMID: 9778222. Dostupné online [cit. 2022-06-21]. ISSN 0004-3591. DOI 10.1002/1529-0131(199810)41:10<1813::AID-ART13>3.0.CO;2-6. PMID 9778222. 
  • VEDELER, C. A.; RAKNES, G.; MYHR, K. M. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology. 2000-09-12, roč. 55, čís. 5, s. 705–707. PMID: 10980740. Dostupné online [cit. 2022-06-21]. ISSN 0028-3878. DOI 10.1212/wnl.55.5.705. PMID 10980740. 
  • GOODIER, Martin R.; LUSA, Chiara; SHERRATT, Sam. Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function. Frontiers in Immunology. 2016, roč. 7, s. 384. PMID: 27725819 PMCID: PMC5035824. Dostupné online [cit. 2022-06-21]. ISSN 1664-3224. DOI 10.3389/fimmu.2016.00384. PMID 27725819. 
  • PILLAY, Janesh; TAK, Tamar; KAMP, Vera M. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cellular and molecular life sciences: CMLS. 2013-10, roč. 70, čís. 20, s. 3813–3827. PMID: 23423530 PMCID: PMC3781313. Dostupné online [cit. 2022-06-21]. ISSN 1420-9071. DOI 10.1007/s00018-013-1286-4. PMID 23423530. 
  • DUMITRU, Claudia A.; MOSES, Katrin; TRELLAKIS, Sokratis. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer immunology, immunotherapy: CII. 2012-08, roč. 61, čís. 8, s. 1155–1167. PMID: 22692756. Dostupné online [cit. 2022-06-21]. ISSN 1432-0851. DOI 10.1007/s00262-012-1294-5. PMID 22692756. 
  • ELGHETANY, M. Tarek. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells, Molecules & Diseases. 2002-03, roč. 28, čís. 2, s. 260–274. PMID: 12064921. Dostupné online [cit. 2022-06-21]. ISSN 1079-9796. DOI 10.1006/bcmd.2002.0513. PMID 12064921. 
  • BJÖRKSTRÖM, Niklas K.; GONZALEZ, Veronica D.; MALMBERG, Karl-Johan. Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection. Journal of Immunology (Baltimore, Md.: 1950). 2008-09-15, roč. 181, čís. 6, s. 4219–4228. PMID: 18768879. Dostupné online [cit. 2022-06-21]. ISSN 1550-6606. DOI 10.4049/jimmunol.181.6.4219. PMID 18768879. 
  • CLÉMENCEAU, Béatrice; VIVIEN, Régine; DEBEAUPUIS, Emilie. FcγRIIIa (CD16) induction on human T lymphocytes and CD16pos T-lymphocyte amplification. Journal of Immunotherapy (Hagerstown, Md.: 1997). 2011-09, roč. 34, čís. 7, s. 542–549. PMID: 21760529. Dostupné online [cit. 2022-06-21]. ISSN 1537-4513. DOI 10.1097/CJI.0b013e31822801d4. PMID 21760529. 
  • JACQUEMONT, Lola; TILLY, Gaëlle; YAP, Michelle. Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. Journal of the American Society of Nephrology: JASN. 2020-04, roč. 31, čís. 4, s. 876–891. PMID: 32165419 PMCID: PMC7191929. Dostupné online [cit. 2022-06-21]. ISSN 1533-3450. DOI 10.1681/ASN.2019080847. PMID 32165419. 
  • GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429 PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN 1097-4172. DOI 10.1016/j.cell.2021.12.040. PMID 35032429. 
  • LU, Yu; HUANG, Yizhou; HUANG, Lei. CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients. BMC immunology. 2020-08-08, roč. 21, čís. 1, s. 46. PMID: 32770940 PMCID: PMC7414545. Dostupné online [cit. 2022-06-22]. ISSN 1471-2172. DOI 10.1186/s12865-020-00375-8. PMID 32770940. 
  • GRIER, Jennifer T.; FORBES, Lisa R.; MONACO-SHAWVER, Linda. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. The Journal of Clinical Investigation. 2012-10, roč. 122, čís. 10, s. 3769–3780. PMID: 23006327 PMCID: PMC3461929. Dostupné online [cit. 2022-06-22]. ISSN 1558-8238. DOI 10.1172/JCI64837. PMID 23006327. 
  • SHARMA, Naveen; VACHER, Jean; ALLISON, James P. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proceedings of the National Academy of Sciences of the United States of America. 2019-05-21, roč. 116, čís. 21, s. 10453–10462. PMID: 31076558 PMCID: PMC6534983. Dostupné online [cit. 2022-06-21]. ISSN 1091-6490. DOI 10.1073/pnas.1819004116. PMID 31076558. 
  • SCHRAMA, David; REISFELD, Ralph A.; BECKER, Jürgen C. Antibody targeted drugs as cancer therapeutics. Nature Reviews. Drug Discovery. 2006-02, roč. 5, čís. 2, s. 147–159. PMID: 16424916. Dostupné online [cit. 2022-06-21]. ISSN 1474-1776. DOI 10.1038/nrd1957. PMID 16424916. 

pubmed.ncbi.nlm.nih.gov

  • GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429 PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN 1097-4172. DOI 10.1016/j.cell.2021.12.040. PMID 35032429. 
  • VIVIER, E.; MORIN, P.; O'BRIEN, C. Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. Journal of Immunology (Baltimore, Md.: 1950). 1991-01-01, roč. 146, čís. 1, s. 206–210. PMID: 1701792. Dostupné online [cit. 2022-06-21]. ISSN 0022-1767. PMID 1701792. 
  • MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937 PMCID: PMC21913. Dostupné online [cit. 2022-06-21]. ISSN 0027-8424. DOI 10.1073/pnas.96.10.5640. PMID 10318937. 
  • ZHANG, Y.; BOESEN, C. C.; RADAEV, S. Crystal structure of the extracellular domain of a human Fc gamma RIII. Immunity. 2000-09, roč. 13, čís. 3, s. 387–395. PMID: 11021536. Dostupné online [cit. 2022-06-22]. ISSN 1074-7613. DOI 10.1016/s1074-7613(00)00038-8. PMID 11021536. 
  • MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937 PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN 0027-8424. DOI 10.1073/pnas.96.10.5640. PMID 10318937. 
  • MAROIS, Louis; PARÉ, Guillaume; VAILLANCOURT, Myriam. Fc gammaRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils. The Journal of Biological Chemistry. 2011-02-04, roč. 286, čís. 5, s. 3509–3519. PMID: 21123174 PMCID: PMC3030356. Dostupné online [cit. 2022-06-21]. ISSN 1083-351X. DOI 10.1074/jbc.M110.169516. PMID 21123174. 
  • GREEN, J. M.; SCHREIBER, A. D.; BROWN, E. J. Role for a glycan phosphoinositol anchor in Fc gamma receptor synergy. The Journal of Cell Biology. 1997-12-01, roč. 139, čís. 5, s. 1209–1217. PMID: 9382867 PMCID: PMC2140207. Dostupné online [cit. 2022-06-21]. ISSN 0021-9525. DOI 10.1083/jcb.139.5.1209. PMID 9382867. 
  • MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937 PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN 0027-8424. DOI 10.1073/pnas.96.10.5640. PMID 10318937. 
  • ANEGÓN, I.; CUTURI, M. C.; TRINCHIERI, G. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. The Journal of Experimental Medicine. 1988-02-01, roč. 167, čís. 2, s. 452–472. PMID: 2831292 PMCID: PMC2188858. Dostupné online [cit. 2022-06-21]. ISSN 0022-1007. DOI 10.1084/jem.167.2.452. PMID 2831292. 
  • ARAMBURU, J.; AZZONI, L.; RAO, A. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. The Journal of Experimental Medicine. 1995-09-01, roč. 182, čís. 3, s. 801–810. PMID: 7650486 PMCID: PMC2192167. Dostupné online [cit. 2022-06-21]. ISSN 0022-1007. DOI 10.1084/jem.182.3.801. PMID 7650486. 
  • GARMAN, S. C.; KINET, J. P.; JARDETZKY, T. S. Crystal structure of the human high-affinity IgE receptor. Cell. 1998-12-23, roč. 95, čís. 7, s. 951–961. PMID: 9875849. Dostupné online [cit. 2022-06-21]. ISSN 0092-8674. DOI 10.1016/s0092-8674(00)81719-5. PMID 9875849. 
  • KOENE, H. R.; KLEIJER, M.; SWAAK, A. J. The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis and Rheumatism. 1998-10, roč. 41, čís. 10, s. 1813–1818. PMID: 9778222. Dostupné online [cit. 2022-06-21]. ISSN 0004-3591. DOI 10.1002/1529-0131(199810)41:10<1813::AID-ART13>3.0.CO;2-6. PMID 9778222. 
  • VEDELER, C. A.; RAKNES, G.; MYHR, K. M. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology. 2000-09-12, roč. 55, čís. 5, s. 705–707. PMID: 10980740. Dostupné online [cit. 2022-06-21]. ISSN 0028-3878. DOI 10.1212/wnl.55.5.705. PMID 10980740. 
  • GOODIER, Martin R.; LUSA, Chiara; SHERRATT, Sam. Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function. Frontiers in Immunology. 2016, roč. 7, s. 384. PMID: 27725819 PMCID: PMC5035824. Dostupné online [cit. 2022-06-21]. ISSN 1664-3224. DOI 10.3389/fimmu.2016.00384. PMID 27725819. 
  • PILLAY, Janesh; TAK, Tamar; KAMP, Vera M. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cellular and molecular life sciences: CMLS. 2013-10, roč. 70, čís. 20, s. 3813–3827. PMID: 23423530 PMCID: PMC3781313. Dostupné online [cit. 2022-06-21]. ISSN 1420-9071. DOI 10.1007/s00018-013-1286-4. PMID 23423530. 
  • DUMITRU, Claudia A.; MOSES, Katrin; TRELLAKIS, Sokratis. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer immunology, immunotherapy: CII. 2012-08, roč. 61, čís. 8, s. 1155–1167. PMID: 22692756. Dostupné online [cit. 2022-06-21]. ISSN 1432-0851. DOI 10.1007/s00262-012-1294-5. PMID 22692756. 
  • ELGHETANY, M. Tarek. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells, Molecules & Diseases. 2002-03, roč. 28, čís. 2, s. 260–274. PMID: 12064921. Dostupné online [cit. 2022-06-21]. ISSN 1079-9796. DOI 10.1006/bcmd.2002.0513. PMID 12064921. 
  • BJÖRKSTRÖM, Niklas K.; GONZALEZ, Veronica D.; MALMBERG, Karl-Johan. Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection. Journal of Immunology (Baltimore, Md.: 1950). 2008-09-15, roč. 181, čís. 6, s. 4219–4228. PMID: 18768879. Dostupné online [cit. 2022-06-21]. ISSN 1550-6606. DOI 10.4049/jimmunol.181.6.4219. PMID 18768879. 
  • CLÉMENCEAU, Béatrice; VIVIEN, Régine; DEBEAUPUIS, Emilie. FcγRIIIa (CD16) induction on human T lymphocytes and CD16pos T-lymphocyte amplification. Journal of Immunotherapy (Hagerstown, Md.: 1997). 2011-09, roč. 34, čís. 7, s. 542–549. PMID: 21760529. Dostupné online [cit. 2022-06-21]. ISSN 1537-4513. DOI 10.1097/CJI.0b013e31822801d4. PMID 21760529. 
  • JACQUEMONT, Lola; TILLY, Gaëlle; YAP, Michelle. Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. Journal of the American Society of Nephrology: JASN. 2020-04, roč. 31, čís. 4, s. 876–891. PMID: 32165419 PMCID: PMC7191929. Dostupné online [cit. 2022-06-21]. ISSN 1533-3450. DOI 10.1681/ASN.2019080847. PMID 32165419. 
  • GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429 PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN 1097-4172. DOI 10.1016/j.cell.2021.12.040. PMID 35032429. 
  • LU, Yu; HUANG, Yizhou; HUANG, Lei. CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients. BMC immunology. 2020-08-08, roč. 21, čís. 1, s. 46. PMID: 32770940 PMCID: PMC7414545. Dostupné online [cit. 2022-06-22]. ISSN 1471-2172. DOI 10.1186/s12865-020-00375-8. PMID 32770940. 
  • GRIER, Jennifer T.; FORBES, Lisa R.; MONACO-SHAWVER, Linda. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. The Journal of Clinical Investigation. 2012-10, roč. 122, čís. 10, s. 3769–3780. PMID: 23006327 PMCID: PMC3461929. Dostupné online [cit. 2022-06-22]. ISSN 1558-8238. DOI 10.1172/JCI64837. PMID 23006327. 
  • SHARMA, Naveen; VACHER, Jean; ALLISON, James P. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proceedings of the National Academy of Sciences of the United States of America. 2019-05-21, roč. 116, čís. 21, s. 10453–10462. PMID: 31076558 PMCID: PMC6534983. Dostupné online [cit. 2022-06-21]. ISSN 1091-6490. DOI 10.1073/pnas.1819004116. PMID 31076558. 
  • SCHRAMA, David; REISFELD, Ralph A.; BECKER, Jürgen C. Antibody targeted drugs as cancer therapeutics. Nature Reviews. Drug Discovery. 2006-02, roč. 5, čís. 2, s. 147–159. PMID: 16424916. Dostupné online [cit. 2022-06-21]. ISSN 1474-1776. DOI 10.1038/nrd1957. PMID 16424916. 

omim.org

springer.com

adisinsight.springer.com

  • Margetuximab - MacroGenics - AdisInsight. adisinsight.springer.com [online]. [cit. 2022-06-21]. Dostupné online. 

worldcat.org

  • GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429 PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN 1097-4172. DOI 10.1016/j.cell.2021.12.040. PMID 35032429. 
  • VIVIER, E.; MORIN, P.; O'BRIEN, C. Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. Journal of Immunology (Baltimore, Md.: 1950). 1991-01-01, roč. 146, čís. 1, s. 206–210. PMID: 1701792. Dostupné online [cit. 2022-06-21]. ISSN 0022-1767. PMID 1701792. 
  • MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937 PMCID: PMC21913. Dostupné online [cit. 2022-06-21]. ISSN 0027-8424. DOI 10.1073/pnas.96.10.5640. PMID 10318937. 
  • TAKAI, Toshiyuki. Roles of Fc receptors in autoimmunity. Nature Reviews Immunology. 2002-08, roč. 2, čís. 8, s. 580–592. Dostupné online [cit. 2022-06-21]. ISSN 1474-1741. DOI 10.1038/nri856. (anglicky) 
  • ZHANG, Y.; BOESEN, C. C.; RADAEV, S. Crystal structure of the extracellular domain of a human Fc gamma RIII. Immunity. 2000-09, roč. 13, čís. 3, s. 387–395. PMID: 11021536. Dostupné online [cit. 2022-06-22]. ISSN 1074-7613. DOI 10.1016/s1074-7613(00)00038-8. PMID 11021536. 
  • GALON, J.; GAUCHAT, J. F.; MAZIÈRES, N. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors.. The Journal of Immunology. 1996-08-01, roč. 157, čís. 3, s. 1184–1192. PMID: 8757624. Dostupné online [cit. 2022-06-21]. ISSN 0022-1767. PMID 8757624. (anglicky) 
  • MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937 PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN 0027-8424. DOI 10.1073/pnas.96.10.5640. PMID 10318937. 
  • AICHELER, Rebecca J.; WANG, Eddie C. Y.; TOMASEC, Peter. Potential for Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity for Control of Human Cytomegalovirus. Antibodies. 2013-12, roč. 2, čís. 4, s. 617–635. Dostupné online [cit. 2022-06-21]. ISSN 2073-4468. DOI 10.3390/antib2040617. (anglicky) 
  • MAROIS, Louis; PARÉ, Guillaume; VAILLANCOURT, Myriam. Fc gammaRIIIb triggers raft-dependent calcium influx in IgG-mediated responses in human neutrophils. The Journal of Biological Chemistry. 2011-02-04, roč. 286, čís. 5, s. 3509–3519. PMID: 21123174 PMCID: PMC3030356. Dostupné online [cit. 2022-06-21]. ISSN 1083-351X. DOI 10.1074/jbc.M110.169516. PMID 21123174. 
  • GREEN, J. M.; SCHREIBER, A. D.; BROWN, E. J. Role for a glycan phosphoinositol anchor in Fc gamma receptor synergy. The Journal of Cell Biology. 1997-12-01, roč. 139, čís. 5, s. 1209–1217. PMID: 9382867 PMCID: PMC2140207. Dostupné online [cit. 2022-06-21]. ISSN 0021-9525. DOI 10.1083/jcb.139.5.1209. PMID 9382867. 
  • MANDELBOIM, O.; MALIK, P.; DAVIS, D. M. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 1999-05-11, roč. 96, čís. 10, s. 5640–5644. PMID: 10318937 PMCID: PMC21913. Dostupné online [cit. 2022-06-22]. ISSN 0027-8424. DOI 10.1073/pnas.96.10.5640. PMID 10318937. 
  • ANEGÓN, I.; CUTURI, M. C.; TRINCHIERI, G. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. The Journal of Experimental Medicine. 1988-02-01, roč. 167, čís. 2, s. 452–472. PMID: 2831292 PMCID: PMC2188858. Dostupné online [cit. 2022-06-21]. ISSN 0022-1007. DOI 10.1084/jem.167.2.452. PMID 2831292. 
  • ARAMBURU, J.; AZZONI, L.; RAO, A. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. The Journal of Experimental Medicine. 1995-09-01, roč. 182, čís. 3, s. 801–810. PMID: 7650486 PMCID: PMC2192167. Dostupné online [cit. 2022-06-21]. ISSN 0022-1007. DOI 10.1084/jem.182.3.801. PMID 7650486. 
  • GARMAN, S. C.; KINET, J. P.; JARDETZKY, T. S. Crystal structure of the human high-affinity IgE receptor. Cell. 1998-12-23, roč. 95, čís. 7, s. 951–961. PMID: 9875849. Dostupné online [cit. 2022-06-21]. ISSN 0092-8674. DOI 10.1016/s0092-8674(00)81719-5. PMID 9875849. 
  • KOENE, H. R.; KLEIJER, M.; SWAAK, A. J. The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis and Rheumatism. 1998-10, roč. 41, čís. 10, s. 1813–1818. PMID: 9778222. Dostupné online [cit. 2022-06-21]. ISSN 0004-3591. DOI 10.1002/1529-0131(199810)41:10<1813::AID-ART13>3.0.CO;2-6. PMID 9778222. 
  • WAINSTEIN, E. The neutrophil FcγRIIIB is associated with renal dysfunction in Wegener's granulomatosis (WG). Arthritis Rheum. 1996-04, roč. 39, čís. 4, s. 615–615. ISSN 0004-3591. 
  • VEDELER, C. A.; RAKNES, G.; MYHR, K. M. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology. 2000-09-12, roč. 55, čís. 5, s. 705–707. PMID: 10980740. Dostupné online [cit. 2022-06-21]. ISSN 0028-3878. DOI 10.1212/wnl.55.5.705. PMID 10980740. 
  • GOODIER, Martin R.; LUSA, Chiara; SHERRATT, Sam. Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function. Frontiers in Immunology. 2016, roč. 7, s. 384. PMID: 27725819 PMCID: PMC5035824. Dostupné online [cit. 2022-06-21]. ISSN 1664-3224. DOI 10.3389/fimmu.2016.00384. PMID 27725819. 
  • PILLAY, Janesh; TAK, Tamar; KAMP, Vera M. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cellular and molecular life sciences: CMLS. 2013-10, roč. 70, čís. 20, s. 3813–3827. PMID: 23423530 PMCID: PMC3781313. Dostupné online [cit. 2022-06-21]. ISSN 1420-9071. DOI 10.1007/s00018-013-1286-4. PMID 23423530. 
  • DUMITRU, Claudia A.; MOSES, Katrin; TRELLAKIS, Sokratis. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer immunology, immunotherapy: CII. 2012-08, roč. 61, čís. 8, s. 1155–1167. PMID: 22692756. Dostupné online [cit. 2022-06-21]. ISSN 1432-0851. DOI 10.1007/s00262-012-1294-5. PMID 22692756. 
  • ELGHETANY, M. Tarek. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells, Molecules & Diseases. 2002-03, roč. 28, čís. 2, s. 260–274. PMID: 12064921. Dostupné online [cit. 2022-06-21]. ISSN 1079-9796. DOI 10.1006/bcmd.2002.0513. PMID 12064921. 
  • BJÖRKSTRÖM, Niklas K.; GONZALEZ, Veronica D.; MALMBERG, Karl-Johan. Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection. Journal of Immunology (Baltimore, Md.: 1950). 2008-09-15, roč. 181, čís. 6, s. 4219–4228. PMID: 18768879. Dostupné online [cit. 2022-06-21]. ISSN 1550-6606. DOI 10.4049/jimmunol.181.6.4219. PMID 18768879. 
  • CLÉMENCEAU, Béatrice; VIVIEN, Régine; DEBEAUPUIS, Emilie. FcγRIIIa (CD16) induction on human T lymphocytes and CD16pos T-lymphocyte amplification. Journal of Immunotherapy (Hagerstown, Md.: 1997). 2011-09, roč. 34, čís. 7, s. 542–549. PMID: 21760529. Dostupné online [cit. 2022-06-21]. ISSN 1537-4513. DOI 10.1097/CJI.0b013e31822801d4. PMID 21760529. 
  • JACQUEMONT, Lola; TILLY, Gaëlle; YAP, Michelle. Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure. Journal of the American Society of Nephrology: JASN. 2020-04, roč. 31, čís. 4, s. 876–891. PMID: 32165419 PMCID: PMC7191929. Dostupné online [cit. 2022-06-21]. ISSN 1533-3450. DOI 10.1681/ASN.2019080847. PMID 32165419. 
  • GEORG, Philipp; ASTABURUAGA-GARCÍA, Rosario; BONAGURO, Lorenzo. Complement activation induces excessive T cell cytotoxicity in severe COVID-19. Cell. 2022-02-03, roč. 185, čís. 3, s. 493–512.e25. PMID: 35032429 PMCID: PMC8712270. Dostupné online [cit. 2022-06-21]. ISSN 1097-4172. DOI 10.1016/j.cell.2021.12.040. PMID 35032429. 
  • LU, Yu; HUANG, Yizhou; HUANG, Lei. CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients. BMC immunology. 2020-08-08, roč. 21, čís. 1, s. 46. PMID: 32770940 PMCID: PMC7414545. Dostupné online [cit. 2022-06-22]. ISSN 1471-2172. DOI 10.1186/s12865-020-00375-8. PMID 32770940. 
  • GRIER, Jennifer T.; FORBES, Lisa R.; MONACO-SHAWVER, Linda. Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. The Journal of Clinical Investigation. 2012-10, roč. 122, čís. 10, s. 3769–3780. PMID: 23006327 PMCID: PMC3461929. Dostupné online [cit. 2022-06-22]. ISSN 1558-8238. DOI 10.1172/JCI64837. PMID 23006327. 
  • SHARMA, Naveen; VACHER, Jean; ALLISON, James P. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proceedings of the National Academy of Sciences of the United States of America. 2019-05-21, roč. 116, čís. 21, s. 10453–10462. PMID: 31076558 PMCID: PMC6534983. Dostupné online [cit. 2022-06-21]. ISSN 1091-6490. DOI 10.1073/pnas.1819004116. PMID 31076558. 
  • SCHRAMA, David; REISFELD, Ralph A.; BECKER, Jürgen C. Antibody targeted drugs as cancer therapeutics. Nature Reviews. Drug Discovery. 2006-02, roč. 5, čís. 2, s. 147–159. PMID: 16424916. Dostupné online [cit. 2022-06-21]. ISSN 1474-1776. DOI 10.1038/nrd1957. PMID 16424916.